相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Sustained hyperosmolarity increses TGF-β1 and Egr-1 expression in the rat renal medulla
Miklos M. Mozes et al.
BMC NEPHROLOGY (2017)
Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-β expression in type-1 diabetic rats
Szabina Czirok et al.
SCIENTIFIC REPORTS (2017)
PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism
Laurent Calvier et al.
CELL METABOLISM (2017)
Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice
Ying Zhang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2016)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
Raymond E. Soccio et al.
CELL METABOLISM (2014)
Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)
Swati Bhattacharyya et al.
JOURNAL OF PATHOLOGY (2013)
Risk factors for chronic kidney disease: an update
Rumeyza Kazancioglu
KIDNEY INTERNATIONAL SUPPLEMENTS (2013)
PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases
Jichun Yang et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease
Futoshi Matsui et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
Amandine Viau et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
KIDNEY INTERNATIONAL (2010)
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
Minghua Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Collagen Structure and Stability
Matthew D. Shoulders et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta
Toru Kawai et al.
LABORATORY INVESTIGATION (2009)
Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis
Yaojun Liang et al.
PEDIATRIC NEPHROLOGY (2009)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction
Masatoshi Kuratsune et al.
NEPHROLOGY (2007)
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation
Georg Hansmann et al.
CIRCULATION (2007)
Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis
L. Martinez-Lostao et al.
LUPUS (2007)
Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-γ agonist:: Molecular mechanism of the antiproteinuric effect of pioglitazone
Ariela Benigni et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
H Ogata et al.
ONCOGENE (2006)
Role of the JAK/STAT signaling pathway in diabetic nephropathy
MB Marrero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Renal fibrosis: New insights into the pathogenesis and therapeutics
YH Liu
KIDNEY INTERNATIONAL (2006)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin
H Nakajima et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis - Association with dephosphorylation of STAT3
Y Kalechman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury
A Sivarajah et al.
AMERICAN JOURNAL OF NEPHROLOGY (2003)
Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
LJ Ma et al.
KIDNEY INTERNATIONAL (2001)
分享论文
